The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors. [electronic resource]
Producer: 20141209Description: 1074-5 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Agents -- pharmacology
- Clinical Trials, Phase II as Topic
- Female
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Hydroxamic Acids -- pharmacology
- Indoles -- pharmacology
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Panobinostat
- Sex Cord-Gonadal Stromal Tumors -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.